Compensatory dendritic cell development mediated by BATF-IRF interactions

Nature

Volumn 490, Issue 7421, 2012, Pages 502-507

  Tussiwand, Roxane ^a   Lee, Wan Ling ^a   Murphy, Theresa L ^a   Mashayekhi, Mona ^a   Kc, Wumesh ^a   Albring, Jörn C ^a   Satpathy, Ansuman T ^a   Rotondo, Jeffrey A ^a   Edelson, Brian T ^a   Kretzer, Nicole M ^a   Wu, Xiaodi ^a   Weiss, Leslie A ^a   Glasmacher, Elke ^b   Li, Peng ^c   Liao, Wei ^c   Behnke, Michael ^a   Lam, Samuel S K ^a   Aurthur, Cora T ^a   Leonard, Warren J ^c   Singh, Harinder ^b   Stallings, Christina L ^a   David Sibley, L ^a   Schreiber, Robert D ^a   Murphy, Kenneth M ^a   more..

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENENTECH INC   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 12; LEUCINE ZIPPER PROTEIN; RECOMBINANT INTERLEUKIN 12; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR BATF; TRANSCRIPTION FACTOR BATF2; TRANSCRIPTION FACTOR BATF3; UNCLASSIFIED DRUG;

BIOCHEMISTRY; COMPENSATION; CYTOLOGY; DEVELOPMENTAL BIOLOGY; GENE EXPRESSION; HOMEOSTASIS; IMMUNE RESPONSE; PATHOGEN; PHYSIOLOGICAL RESPONSE; PROTEIN; RODENT; VACCINE;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE ACTIVATION; IN VITRO STUDY; IN VIVO STUDY; MEDIATOR; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUBERCULOSIS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD8; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL LINEAGE; CTLA-4 ANTIGEN; DENDRITIC CELLS; FEMALE; FIBROSARCOMA; GENE EXPRESSION REGULATION; INTEGRIN ALPHA CHAINS; INTERFERON REGULATORY FACTORS; INTERLEUKIN-10; INTERLEUKIN-12; LEUCINE ZIPPERS; MALE; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; ONCOGENE PROTEIN P65(GAG-JUN); PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; REPRESSOR PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER; TOXOPLASMA;

MUS;

EID: 84867884822     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature11531     Document Type: Article

References (54)

1. Dorsey, M. J. et al. B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family. Oncogene 11, 2255-2265 (1995).
2. Wagner, E. F. & Eferl, R. Fos/AP-1 proteins in bone and the immune system. Immunol. Rev. 208, 126-140 (2005).
3. Williams, K. L. et al. Characterization of murine BATF: a negative regulator of activator protein-1 activity in the thymus. Eur. J. Immunol. 31, 1620-1627 (2001).
4. Echlin, D. R., Tae, H. J., Mitin, N. & Taparowsky, E. J. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Oncogene 19, 1752-1763 (2000).
5. Schraml, B. U. et al. The AP-1 transcription factor Batf controls TH17 differentiation. Nature 460, 405-409 (2009).
6. Ise, W. et al. The transcription factor BATF controls the global regulators of classswitch recombination in both B cells and T cells. Nature Immunol. 12, 536-543 (2011).
7. Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8a1 dendritic cells in cytotoxic T cell immunity. Science 322, 1097-1100 (2008).
8. Edelson, B. T. et al. Peripheral CD1031 dendritic cells form a unified subset developmentally related to CD8a1 conventional dendritic cells. J. Exp. Med. 207, 823-836 (2010).
9. Betz, B. C. et al. Batf coordinatesmultiple aspects of B and T cell function required for normal antibody responses. J. Exp. Med. 207, 933-942 (2010).
10. Mashayekhi, M. et al. CD8a1 dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 35, 249-259 (2011).
11. Bar-On, L. et al. CX3CR11 CD8a1 dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proc. Natl Acad. Sci. USA 107, 14745-14750 (2010).
12. Behnke, M. S. et al. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc. Natl Acad. Sci. USA 108, 9631-9636 (2011).
13. Ginhoux, F. et al. The origin and development of nonlymphoid tissueCD1031 DCs. J. Exp. Med. 206, 3115-3130 (2009).
14. Modlin, R. L. & Barnes, P. F. IL12 and the human immune response to mycobacteria. Res. Immunol. 146, 526-531 (1995).
15. denHaan, J. M., Lehar, S. M.&Bevan, M. J.CD81but notCD82dendritic cells crossprime cytotoxic T cells in vivo. J. Exp. Med. 192, 1685-1696 (2000).
16. Wilson, N. S. et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nature Immunol. 7, 165-172 (2006).
17. Aliberti, J. et al. Essential role for ICSBPin the in vivo development ofmurineCD8a1 dendritic cells. Blood 101, 305-310 (2003).
18. Tailor, P., Tamura, T., Morse, H. C. & Ozato, K. The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse. Blood 111, 1942-1945 (2008).
19. Edelson, B. T. et al. Batf3-dependentCD11blow/2peripheral dendritic cells areGMCSF-independent and are not required for Th cell priming after subcutaneous immunization. PLoS ONE 6, e25660 (2011).
20. Marquis, J. F., Lacourse, R., Ryan, L.,North, R. J.&Gros, P. Disseminated and rapidly fatal tuberculosis in mice bearing a defective allele at IFN regulatory factor 8. J. Immunol. 182, 3008-3015 (2009).
21. Jackson, J. T. et al. Id2 expression delineates differential checkpoints in the genetic program of CD8a1 and CD1031 dendritic cell lineages. EMBO J. 30, 2690-2704 (2011).
22. Edelson, B. T. et al. CD8a1 dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes. Immunity 35, 236-248 (2011).
23. Su, Z. Z. et al. Cloning and characterization of SARI (suppressor of AP-1, regulated by IFN). Proc. Natl Acad. Sci. USA 105, 20906-20911 (2008).
24. Ravasi, T. et al. An atlas of combinatorial transcriptional regulation in mouse and man. Cell 140, 744-752 (2010).
25. Brü stle, A. et al. The development of inflammatory TH17 cells requires interferonregulatory factor 4. Nature Immunol. 8, 958-966 (2007).
26. Klein, U. et al. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nature Immunol. 7, 773-782 (2006).
27. Tamura, T. & Ozato, K. ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J. Interferon Cytokine Res. 22, 145-152 (2002).
28. Sciammas, R. et al. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity 25, 225-236 (2006).
29. Glasmacher, E. et al. A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science. (in the press).
30. Li, P. et al. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature http://dx.doi.org/10.1038/nature11530 (19 September 2012).
31. Brass, A. L., Zhu, A. Q. & Singh, H. Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers. EMBO J. 18, 977-991 (1999).
32. Chen, L., Glover, J. N., Hogan, P. G., Rao, A. & Harrison, S. C. Structure of the DNAbinding domains from NFAT, Fos and Jun bound specifically to DNA. Nature 392, 42-48 (1998).
33. Eisenbeis, C. F., Singh, H.&Storb, U. Pip, a novel IRF familymember, is a lymphoidspecific, PU.1-dependent transcriptional activator. Genes Dev. 9, 1377-1387 (1995).
34. Heng, T. S. & Painter, M. W. The Immunological Genome Project: networks of gene expression in immune cells. Nature Immunol. 9, 1091-1094 (2008).
35. Ranganath, S. et al. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161, 3822-3826 (1998).
36. Gorman, J. R. et al. The Igk enhancer influences the ratio of Igk versus Igl B lymphocytes. Immunity 5, 241-252 (1996).
37. Iiizumi, S. et al. Simple one-week method to construct gene-targeting vectors: application to production of human knockout cell lines. Biotechniques 41, 311-316 (2006).
38. Edelson, B. T. et al. CD8a1 dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes. Immunity 35, 236-248 (2011).
39. Mashayekhi, M. et al. CD8a1 dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 35, 249-259 (2011).
40. Edelson, B. T. et al. Peripheral CD1031 dendritic cells form a unified subset developmentally related to CD8a1 conventional dendritic cells. J. Exp. Med. 207, 823-836 (2010).
41. Saeij, J. P., Boyle, J. P., Grigg, M. E., Arrizabalaga, G. & Boothroyd, J. C. Bioluminescence imaging of Toxoplasma gondii infection in living mice reveals dramatic differences between strains. Infect. Immun. 73, 695-702 (2005).
42. Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8a1 dendritic cells in cytotoxic T cell immunity. Science 322, 1097-1100 (2008).
43. Matsushita, H. et al.Cancer exome analysis reveals a T-cell- dependentmechanism of cancer immunoediting. Nature 482, 400-404 (2012).
44. Satpathy, A. T. et al. Zbtb46 expression distinguishes classical dendritic cells and their committed progenitors from other immune lineages. J. Exp. Med. 209, 1135-1152 (2012).
45. Schraml, B. U. et al. The AP-1 transcription factor Batf controls TH17 differentiation. Nature 460, 405-409 (2009).
46. Li, C. & Wong, W. H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl Acad. Sci. USA 98, 31-36 (2001).
47. Bending, D. et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 119, 565-572 (2009).
48. Ise, W. et al. The transcription factor BATF controls the global regulators of classswitch recombination in both B cells and T cells. Nature Immunol. 12, 536-543 (2011).
49. Ranganath, S. et al. GATA-3-dependent enhancer activity in IL-4 gene regulation. J. Immunol. 161, 3822-3826 (1998).
50. Sedy, J. R. et al. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nature Immunol. 6, 90-98 (2005).
51. Kanbe, E. & Zhang, D. E. A simple and quick method to concentrate MSCV retrovirus. Blood Cells Mol. Dis. 33, 64-67 (2004).
52. Dignam, J. D., Lebovitz, R. M. & Roeder, R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11, 1475-1489 (1983).
53. Szabo, S. J., Gold, J. S., Murphy, T. L. & Murphy, K. M. Identification of cis-acting regulatory elements controlling interleukin-4 gene expression in T cells: roles for NF-Y and NF-ATc. Mol. Cell. Biol. 13, 4793-4805 (1993); erratum 13, 5928 (1993).
54. Eisenbeis, C. F., Singh, H.&Storb, U. Pip, a novel IRF familymember, is a lymphoidspecific, PU.1-dependent transcriptional activator. Genes Dev. 9, 1377-1387 (1995).